Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients

Histopathology

Volumn 34, Issue 5, 1999, Pages 399-404

  Charton Bain, M C ^a,b   Terris, B ^a   Dauge, M C H ^a   Marche, C ^a   Walker, F ^a   Bouchaud, O ^a   Xerri, L ^b   Potet, F ^a  

^a BICHAT HOSPITAL   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

AIDS; CD1a; Immunohistochemistry; Langerhans cells; Morphometry; Oesophagus

Indexed keywords

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LANGERHANS CELL; MALE; PRIORITY JOURNAL; TARGET CELL; VIRUS CELL INTERACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, CD1; CASE-CONTROL STUDIES; CELL COUNT; ESOPHAGUS; FEMALE; HUMANS; LANGERHANS CELLS; MALE; MIDDLE AGED; MUCOUS MEMBRANE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032982167     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00653.x     Document Type: Article

References (26)

1. 1. Belsito DV, Sanchez MR, Baer RL et al. Reduced Langerhans cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1984; 310; 1279-1282.
2. 2. Tschachler E, Groh V, Popovic M et al. Epidermal Langerhans cells: a target for HTLV-III/LAV infection. J. Invest. Dermatol. 1987: 88; 233-237.
3. 3. Rappersberger K, Gartner S, Schenk et al. Langerhans cells are an actual site of HIV-1 replication. Intervirology 1988; 29; 185-194.
4. 4. Geboes K, De Wolf-Peters C, Rutgeerts P et al. Lymphocytes and Langerhans cells in the human oesphageal epithelium. Virchows Arch. 1983: 401; 45-55.
5. 5. Terris B, Potel F. Structure and role of Langerhans cells in the human oesophageal epithelium. Digestion 1995: Suppl. 1; 9-14.
6. 6. Bach MC, Howell DA, Valenti AJ et al. Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 1990; 112; 465-466.
7. 7. Kotler DP, Reka S, Orenstein et al. Chronic idiopathic oesophageal ulceration in the acquired immunodeficiency syndrome. J. Clin. Gastroenterol. 1992; 15; 284-290.
8. 8. Acquired Immunodeficiency Syndrome (AIDS). 1987 revision of CDC/WHO case definition for AIDS. Weekly Epidemiol. Rec. 1988; 63; 1-8.
9. 9. Mason DY, Cordell JL, Abdulaziz Z et al. Preparation of peroxidase antiperoxidase (PAP) complexes for immunohistological labelling of mononoclonal antibodies. J. Histochem. Cytochem. 1982: 30; 1114-1122.
10. 10. Gervaz E, Dauge-Geffroy MC, Sobhani I et al. Quantitative analysis of the immune cells in the anal mucosa. Path Res. Pract. 1995; 191; 1067-1071.
11. 11. De Fraissinette A, Schmitt D, Thivolet J. Langerhans cells of human mucosa. J. Dermatol. 1989; 16; 255-262.
12. 12. Teunissen MBM. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem. J. 1992; 24; 697-716.
13. 13. Kirkpatrick CH, Davis KC, Horsburgh CR. Reduced Ia positive Langerhans cells in AIDS. N. Engl. J. Med. 1984; 341; 857-858.
14. 14. Braathen LR, Ramirez G, Kunze ROF et al. Langerhans cell as primary target cells for HIV infection. Lancet 1987; ii; 1094.
15. 15. Spinillo A, Tenti P, Zappatore R et al. Langerhans cell counts and cervical intraepithelial neoplasia in women with human immuno-deficiency virus infection. Gynerol. Oncol. 1993; 48; 210-213.
16. 16. Sporri B, von Overbeck J, Brand CU et al. Reduced number of Langerbans cells in oral mucosal washings from HIV-1 seropositives. J. Oral Pathol. Med. 1994; 23; 399-402.
17. 17. Daniels TE, Greenspan D, Greenspan JS et al. Absence of Langerhans cells in oral hairy leucoplakia, an AIDS-associated lesion. J. Invest. Dermatol. 1987; 89; 178-182.
18. 18. Braathen LR, Ramirez G, Kunze R et al. Latent infection of epidermal Langerhans cells in HIV-positive individuals. Res. Virol. 1991; 142; 119-121.
19. 19. Schmitt D, Dezutter-Dambuyant C. Epidermal and mucosal dendritic cells and HIV1 infection. Pathol. Res. Pract 1944; 190; 955-959.
20. 20. Gielen V, Schmitt D, Dezutter-Dambuyant C et al. AIDS and Langerhans cells: CD4 antigenic site density modification evidenced by single-cell immunogold labeling. Reg. Immunol. 1989: 2; 7-13.
21. 21. Gianetti A, Zambruno G, Cimarelli A et al. Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J. Acquir. Immune Defic. Syndr. 1993; 6; 329-333.
22. 22. Bonacini M, Young T, Laine L. The causes of oesophageal symptoms in human immunodeficiency virus infection. Arch. Intern. Med. 1991; 151; 1567-1572.
23. 23. Wilcox CM. Oesophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis, and management. Am. J. Med. 1992; 92; 412-420.
24. 24. Wilcox CM, Schwartz DA, Clark WS. Oesophageal ulceration in human immunodeficiency virus infection: causes, response to therapy. and long-term outcome. Ann. Intern. Med. 1995: 123; 143-149.
25. 25. Kitchen VS, Helbert M, Francis ND et al. Epstein Barr virus associated oesophageal ulcers in AIDS. Gut 1990; 31; 1223-1225.
26. 26. Wilcox CM, Zaki SR, Coffield LM et al. Evaluation of idiopathic oesophageal ulceration for human immunodeficiency virus. Mod. Pathol. 1995: 8; 568-572.